Cargando…

Circulating miRNAs in Women with Polycystic Ovary Syndrome: A Longitudinal Cohort Study

Background: Women with polycystic ovary syndrome (PCOS) often change their metabolic profile over time to decrease levels of androgens while often gaining a propensity for the development of the metabolic syndrome. Recent discoveries indicate that microRNAs (miRNAs) play a role in the development of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Udesen, Pernille B., Sørensen, Anja E., Svendsen, Rikke, Frisk, Nanna L. S., Hess, Anne L., Aziz, Mubeena, Wissing, Marie Louise M., Englund, Anne Lis M., Dalgaard, Louise T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093401/ https://www.ncbi.nlm.nih.gov/pubmed/37048055 http://dx.doi.org/10.3390/cells12070983

Ejemplares similares

Metformin decreases miR-122, miR-223 and miR-29a in women with polycystic ovary syndrome
por: Udesen, Pernille Bækgaard, et al.
Publicado: (2020)

Levels of circulating insulin cell-free DNA in women with polycystic ovary syndrome – a longitudinal cohort study
por: Udesen, Pernille Bækgaard, et al.
Publicado: (2019)

MicroRNAs Related to Polycystic Ovary Syndrome (PCOS)
por: Sørensen, Anja Elaine, et al.
Publicado: (2014)

Hyperandrogenism and Metabolic Syndrome Are Associated With Changes in Serum-Derived microRNAs in Women With Polycystic Ovary Syndrome
por: Sørensen, Anja E., et al.
Publicado: (2019)

Circulating microRNAs for Early Diagnosis of Ovarian Cancer: A Systematic Review and Meta-Analysis
por: Frisk, Nanna Lond Skov, et al.
Publicado: (2023)

Circulating microRNA as Biomarkers for Gestational Diabetes Mellitus—A Systematic Review and Meta-Analysis
por: Dinesen, Sofie, et al.
Publicado: (2023)

Extracellular microRNAs in Relation to Weight Loss—A Systematic Review and Meta-Analysis
por: Veie, Camilla H. B., et al.
Publicado: (2023)

Asthma severity and fertility outcome in women with polycystic ovary syndrome: a registry-based study
por: Zierau, Louise, et al.
Publicado: (2018)

The Temporal Profile of Circulating miRNAs during Gestation in Overweight and Obese Women with or without Gestational Diabetes Mellitus
por: Sørensen, Anja Elaine, et al.
Publicado: (2022)

Serum polychlorinated biphenyl levels and circulating miRNAs in non-obese women with and without polycystic ovary syndrome
por: Brennan, Edwina, et al.
Publicado: (2023)

Differential expression of plasma‑derived exosomal miRNAs in polycystic ovary syndrome as a circulating biomarker
por: Liu, Yanfei, et al.
Publicado: (2023)

Probable discrepancy in the prevalence of polycystic ovarian syndrome (PCOS)
por: Javed, Haseeba, et al.
Publicado: (2022)

Expression Patterns and Correlations with Metabolic Markers of Zinc Transporters ZIP14 and ZNT1 in Obesity and Polycystic Ovary Syndrome
por: Maxel, Trine, et al.
Publicado: (2017)

Polycystic ovary syndrome and circulating inflammatory markers
por: Zafari Zangeneh, Farideh, et al.
Publicado: (2017)

Circulating and Adipose Tissue miRNAs in Women With Polycystic Ovary Syndrome and Responses to High-Intensity Interval Training
por: Lionett, Sofie, et al.
Publicado: (2020)

The Role of Microglia in the Polycystic Ovary Syndrome (PCOS)-Like Brain
por: Sati, Aisha, et al.
Publicado: (2021)

Obesity and Insulin Resistance Are the Main Determinants of Postprandial Lipoprotein Dysmetabolism in Polycystic Ovary Syndrome
por: Kyaw Tun, Tommy, et al.
Publicado: (2016)

Polycystic Ovary Syndrome
por: Franks, Stephen
Publicado: (1998)

Major determinants of circulating myostatin in polycystic ovary syndrome
por: Arpaci, Haldun
Publicado: (2019)

microRNA-155 inhibition restores Fibroblast Growth Factor 7 expression in diabetic skin and decreases wound inflammation
por: Moura, João, et al.
Publicado: (2019)

Complementary Therapy in Polycystic Ovary Syndrome
por: Aquino, C. I., et al.
Publicado: (2014)

MiRNAs Regulating Insulin Sensitivity Are Dysregulated in Polycystic Ovary Syndrome (PCOS) Ovaries and Are Associated With Markers of Inflammation and Insulin Sensitivity
por: Cirillo, Francesca, et al.
Publicado: (2019)

Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis
por: Sathyapalan, T., et al.
Publicado: (2015)

Identification of key genes and miRNAs related to polycystic ovary syndrome by comprehensive analysis of microarray
por: Sun, Ziqian, et al.
Publicado: (2022)

Therapeutic potential of exosomes/miRNAs in polycystic ovary syndrome induced by the alteration of circadian rhythms
por: Chen, Wei-hong, et al.
Publicado: (2022)

Prospective Risk of Type 2 Diabetes in Normal Weight Women with Polycystic Ovary Syndrome
por: Glintborg, Dorte, et al.
Publicado: (2022)

Features of Polycystic Ovary Syndrome in adolescence
por: Tsikouras, P, et al.
Publicado: (2015)

Myoinositol vs. Metformin in Women with Polycystic Ovary Syndrome: A Randomized Controlled Clinical Trial
por: Ravn, Pernille, et al.
Publicado: (2022)

The effect of atorvastatin on pancreatic beta cell requirement in women with polycystic ovary syndrome
por: Sathyapalan, Thozhukat, et al.
Publicado: (2017)

Pregnancy in polycystic ovary syndrome
por: Kamalanathan, Sadishkumar, et al.
Publicado: (2013)

The inositols and polycystic ovary syndrome
por: Kalra, Bharti, et al.
Publicado: (2016)

On the Therapy for Polycystic Ovary Syndrome
por: Unfer, Vittorio, et al.
Publicado: (2017)

Kisspeptin and Polycystic Ovary Syndrome
por: Tang, Rong, et al.
Publicado: (2019)

Polycystic Ovary Syndrome in Adolescence
por: Deans, Rebecca
Publicado: (2019)

Update on polycystic ovary syndrome
por: Kim, Jin Ju
Publicado: (2021)

Quercetin and polycystic ovary syndrome
por: Ma, Congshun, et al.
Publicado: (2022)

Circulating SCUBE1 levels in women with polycystic ovary syndrome
por: Erol, Onur, et al.
Publicado: (2018)

The Effect of Exenatide on Cardiovascular Risk Markers in Women With Polycystic Ovary Syndrome
por: Dawson, Alison J., et al.
Publicado: (2019)

Role of Anti-Müllerian Hormone in the Pathogenesis of Polycystic Ovary Syndrome
por: Dewailly, Didier, et al.
Publicado: (2020)

Endometriosis and polycystic ovary syndrome are diametric disorders
por: Dinsdale, Natalie L., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dcje66vmq91ejl508i5k71elvr